featured
Irinotecan Plus Cisplatin vs Irinotecan Alone in Patients With Advanced Gastric Cancer Refractory to S-1 Monotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomised Phase III Trial of Second-Line Irinotecan Plus Cisplatin Versus Irinotecan Alone in Patients With Advanced Gastric Cancer Refractory to S-1 Monotherapy: TRICS Trial
Eur. J. Cancer 2015 Mar 19;[EPub Ahead of Print], K Nishikawa, K Fujitani, H Inagaki, Y Akamaru, S Tokunaga, M Takagi, S Tamura, N Sugimoto, T Shigematsu, T Yoshikawa, T Ishiguro, M Nakamura, S Morita, Y Miyashita, A Tsuburaya, J Sakamoto, T TsujinakaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.